Announcements Trials
Browse Landscape

Phase

Phase NA 42Phase 2 13Phase 1/2 12Phase 1 9Phase 2/3 7Phase 3 2Phase EARLY_PHASE1 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 1Dermatologic 1

Conditions

Uterine Cervical Dysplasia 1Squamous Intraepithelial Lesions 1Carcinoma, Basal Cell 1

Interventions

Cisplatin 726Carboplatin 609Paclitaxel 579Cyclophosphamide 516Radiotherapy 511Docetaxel 477Fluorouracil 454Gemcitabine 438Doxorubicin 383Capecitabine 362Dexamethasone 328Oxaliplatin 289pembrolizumab 283Leucovorin 283Bevacizumab 275Etoposide 272Vincristine 270Rituximab 246Prednisone 223Pemetrexed 217Cytarabine 205Drug Therapy 194Trastuzumab 176Irinotecan 174Methotrexate 171Lenalidomide 137Nivolumab 136Filgrastim 135Epirubicin 129Tamoxifen 128

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Electroporation × Clear all
NCT03185013 2023-07-27

REVEAL 1

Inovio Pharmaceuticals

Phase 3 Completed
201 enrolled 23 charts
Gynecologic

Squamous Intraepithelial Lesions, Uterine Cervical Dysplasia

NCT05046262 2021-09-16

Calcium Electroporation for Basal Cell Carcinomas - Proof of Concept Study

Bispebjerg Hospital

Phase 3 Unknown
25 enrolled
Dermatologic

Carcinoma, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡